BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

44 related articles for article (PubMed ID: 1825563)

  • 1. Determination of platelet-activating factor in biological samples by high resolution mass spectrometry.
    Magni F; Berti F; De Angelis L; Rossoni G; Galli G
    Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():327-30. PubMed ID: 1825563
    [No Abstract]   [Full Text] [Related]  

  • 2. A novel method for the analysis of PAF and alkyl-ether phospholipids by mass spectrometry.
    Balazy M; Cluzel J; Bazan NG
    Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():323-6. PubMed ID: 1825562
    [No Abstract]   [Full Text] [Related]  

  • 3. Molecular species of platelet-activating factor generated by human neutrophils challenged with ionophore A23187.
    Oda M; Satouchi K; Yasunaga K; Saito K
    J Immunol; 1985 Feb; 134(2):1090-3. PubMed ID: 3917470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of MK-287, a new platelet-activating factor antagonist, in plasma and serum by gas chromatography chemical ionization mass spectrometry.
    Fisher AL; Morris MJ; Gilbert JD
    Biol Mass Spectrom; 1991 Jul; 20(7):408-14. PubMed ID: 1932155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of AGEPC generated from human neutrophils and rat skin and muscle tissues by a selected ion monitoring technique of GC/MS.
    Saito K; Satouchi K; Oda M; Nakayama R
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 15():701-3. PubMed ID: 2936200
    [No Abstract]   [Full Text] [Related]  

  • 6. Biological activity of lipids of pine pollen on platelet aggregation in correlation with the platelet activating factor.
    Siafaka-Kapadai A; Demopoulos CA; Andrikopoulos NK
    Biochem Int; 1986 Jan; 12(1):33-41. PubMed ID: 3947373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of platelet activating factor in human saliva by gas chromatography/mass spectrometry.
    Christman BW; Blair IA
    Biomed Environ Mass Spectrom; 1989 Apr; 18(4):258-64. PubMed ID: 2706378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitation of platelet-activating factor in biological samples using liquid chromatography/mass spectrometry with column-switching technique.
    Oda Y; Mano N; Asakawa N
    Anal Biochem; 1995 Oct; 231(1):141-50. PubMed ID: 8678293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative analysis of platelet activating factor using fast atom bombardment/tandem mass spectrometry.
    Haroldsen PE; Gaskell SJ
    Biomed Environ Mass Spectrom; 1989 Jun; 18(6):439-44. PubMed ID: 2504312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet-activating factor.
    Owen JS; Thomas MJ; Wykle RL
    Methods Enzymol; 2007; 434():105-16. PubMed ID: 17954244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitation of platelet-activating factor by gas chromatography-mass spectrometry.
    Clay KL
    Methods Enzymol; 1990; 187():134-42. PubMed ID: 2233339
    [No Abstract]   [Full Text] [Related]  

  • 12. Quantitative analysis of platelet-activating factor by gas chromatography-negative-ion chemical ionization mass spectrometry.
    Pickett WC; Ramesha CS
    Methods Enzymol; 1990; 187():142-52. PubMed ID: 2233340
    [No Abstract]   [Full Text] [Related]  

  • 13. Determination of polybrominated biphenyls in Tasmanian devils (Sarcophilus harrisii) by gas chromatography coupled to electron capture negative ion tandem mass spectrometry or electron ionization high-resolution mass spectrometry.
    Vetter W; Recke Rv; Symons R; Pyecroft S
    Rapid Commun Mass Spectrom; 2008 Dec; 22(24):4165-70. PubMed ID: 19034893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Analysis of platelet-activating factor and its effect on the lung].
    Maki N; Kanda Y; Suzuki T; Miyauchi K; Wada Y; Johnston JM
    Rinsho Byori; 1993 Feb; 41(2):160-9. PubMed ID: 8361018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Species-specific variations in the molecular heterogeneity of the platelet-activating factor.
    Ramesha CS; Pickett WC
    J Immunol; 1987 Mar; 138(5):1559-63. PubMed ID: 3100641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Highly sensitive gas chromatographic--mass spectrometric method for the determination of platelet-activating factor in human blood.
    Yamada K; Asano O; Yoshimura T; Katayama K
    J Chromatogr; 1988 Dec; 433():243-7. PubMed ID: 3235552
    [No Abstract]   [Full Text] [Related]  

  • 17. Myocardial reperfusion injury. Platelet-activating factor stimulates polymorphonuclear leukocyte hydrogen peroxide production during myocardial reperfusion.
    Ko W; Hawes AS; Lazenby WD; Calvano SE; Shin YT; Zelano JA; Antonacci AC; Isom OW; Krieger KH
    J Thorac Cardiovasc Surg; 1991 Aug; 102(2):297-308. PubMed ID: 1865703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analytical method for determination of dinitropyrenes using gas chromatography-high-resolution mass spectrometry.
    Nakao T; Aozasa O; Ohta S; Miyata H
    J Chromatogr A; 2007 Jul; 1157(1-2):352-7. PubMed ID: 17482629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural identification of platelet activating factor in psoriatic scale.
    Mallet AI; Cunningham FM
    Biochem Biophys Res Commun; 1985 Jan; 126(1):192-8. PubMed ID: 3970690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Congener specific determination of PCBs in human blood using gel permeation chromatography (GPC) and high resolution gas chromatography/high resolution mass spectrometry (HRGC/HRMS)].
    Hori T; Tobiishi K; Ashizuka Y; Nakagawa R; Todaka T; Hirakawa H; Iida T
    Fukuoka Igaku Zasshi; 2005 May; 96(5):220-6. PubMed ID: 15997777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.